Effectiveness and Cost-Effectiveness of Imatinib for First-Line Treatment of Chronic Myeloid Leukaemia in Chronic Phase: A Systematic Review and Economic Analysis

Health Technology Assessment - United Kingdom
doi 10.3310/hta8280
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Institute for Health Research

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy